Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
96.53 CHF | +0.67% |
|
+3.68% | +13.80% |
24/06 | Foreign banks target Switzerland after UBS takeover of Credit Suisse | RE |
24/06 | NOVARTIS AG : Barclays reaffirms its Sell rating | ZD |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.80% | 219B | |
+55.19% | 815B | |
+45.31% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.06% | 247B | |
+3.31% | 229B | |
+10.86% | 171B | |
-2.78% | 159B | |
+1.04% | 122B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, Q2 2023 Earnings Call, Jul 18, 2023